Elevated N-Glycosylation Contributes to the Cisplatin Resistance of Non-Small Cell Lung Cancer Cells Revealed by Membrane Proteomic and Glycoproteomic Analysis

Chemoresistance is the major restriction on the clinical use of cisplatin. Aberrant changes in protein glycosylation are closely associated with drug resistance. Comprehensive study on the role of protein glycosylation in the development of cisplatin resistance would contribute to precise elucidatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Wenjuan, Zheng, Shanshan, Mao, Yonghong, Wang, Shisheng, Zhong, Yi, Cao, Wei, Su, Tao, Gong, Meng, Cheng, Jingqiu, Zhang, Yong, Yang, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728018/
https://www.ncbi.nlm.nih.gov/pubmed/35002739
http://dx.doi.org/10.3389/fphar.2021.805499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728018/
https://www.ncbi.nlm.nih.gov/pubmed/35002739
http://dx.doi.org/10.3389/fphar.2021.805499

Ejemplares similares